The global race to be the first to deliver a viable Covid-19 vaccine has also highlighted the importance of a country being able to produce life-saving medication.

Considering South Africa’s battle with HIV/Aids, and TB, it still relies heavily on China and India for its advanced pharmaceutical intermediates (APIs). These are the actual drug component, or central ingredient in medication. So what will it take to get South Africa on par with countries like China, and how much money and lives will it save to produce these medications on home soil?

We’re joined by the Research Chair in Microfluidic Bio/Chemical Processing at Nelson Mandela University, Professor Paul Watts…